Carbohydrates are abbreviated 'Glc.' Superscripts indicate the carbons in the glucose ring that link the two carbohydrates.
Coronary artery disease (CAD), a leading cause of morbidity and mortality throughout the world, has been associated with a variety of biomedical and psychological factors. 1, 2) In Western populations, CAD and myocardial ischemia are the most common causes of heart failure, which occurs when the heart fails to pump blood at a rate needed to meet metabolic requirements under normal cardiac filling pressure. 3) Patients who survive myocardial infarction resulting from CAD have an approximately 3-fold increased risk of developing left ventricular systolic dysfunction (systolic ejection fraction Ͻ45%) thereafter. 4) However, our understanding of CAD pathophysiology has undergone a remarkable evolution over the past decade, and the likelihood of survival from myocardial infarction has almost doubled in some countries. 5) Ginseng, a widely recognized herbal medicine, has been used extensively in Korean, Japanese, and Chinese medicine, and has become increasingly popular in the Western world for its alleged tonic effects and possible curative and restorative properties. Accumulating clinical evidence supports the potential benefits of ginseng roots in the cardiovascular system. For example, administration of ginsenosides, the active ingredients extracted from Panax ginseng, has been shown to decrease blood pressure in both hypertensive patients and experimental animals. 6, 7) The anti-hypertensive effects of ginsenosides may be at least partially due to their ability to inhibit vascular tone. 8) Indeed, ginsenosides have been shown to concentration-dependently relax the prostaglandin F2a-induced contraction of isolated rabbit pulmonary arteries 9) and the phenylephrine-induced contraction of isolated rabbit and rat aortas. 7) Studies examining the effect of various purified ginsenosides on vascular contractions have demonstrated that ginsenoside Rg 3 , which is one of the protopanaxadiol ginsenosides, acts as the most potent vasodilator among ginsenosides. 10) Ginsenoside Rg 3 exists as a pair of stereoisomers, with a change in the position of the hydroxyl group on carbon-20 differentiating between the epimers, 20(R)-ginsenoside and 20(S)-ginsenoside 11) (Fig. 1) . Although we previously reported that 20(R)-and 20(S)-ginsenoside Rg 3 regulate voltage-dependent ion channel activities in a stereospecific manner, 12) no previous work has examined the effects of these epimers on vasorelaxation.
Here, we investigated the relaxation effects of 20(S)-and 20(R)-ginsenoside Rg 3 on high K ϩ -and 5-HT-induced contraction of swine coronary arteries with intact-or endothelium-denuded artery rings. Our results revealed that 20(S)-and 20(R)-ginsenoside Rg 3 exhibit differential relaxation effects in swine coronary arteries. Figure 1 shows the chemical structures of 20(R)-and 20(S)-ginsenoside Rg 3 , which were kindly provided by the Korea Ginseng Cooperation (Daejon, South Korea). L (a 1C )-type Ca 2ϩ channel a subunits and their auxiliary subunits were kindly provided by Dr. K. P. Campbell (University of Iowa, IA, U.S.A.). KCl, serotonin, and other reagents were purchased from Sigma (MO, U.S.A.). (control solution) . The LCC arteries were cleaned of loose connective tissue and then cut into eight rings 2-3 mm in width. Each specimen was divided into intact and endothelium-denuded samples. The four of the eight was used with endothelium intact and the endothelium of the remaining four was removed. The endothelium was removed by gently rubbing the inner surface of the vessel with a cotton thread moistened with physiological PSS. The removal of the endothelium was confirmed by stabilization of the specimen with 25 mM KCl and further confirm by treatment with acetylcholine (10 mM), which does not induce relaxation in endothelium-denuded coronary artery.
MATERIALS AND METHODS

Materials
Stereospecific Effects of Ginsenoside Rg 3 Epimers on Swine Coronary Artery Contractions
13) The prepared LCC artery rings were suspended horizontally between two stainless steel stirrups in organ chambers filled with 3 ml of control solution at 37.8°C (pH 7.4) and bubbled with 95% O 2 and 5% CO 2 . One of the stirrups was anchored to the organ chamber and the other was connected to a transducer coupler (FT03; Grass, RI, U.S.A.) connected to a recording system (AD Instrument, Sydney, Australia). The LCC arteries rings were progressively stretched to the optimal tension (2 g) prior to addition of 25 mM KCl or 3 mM 5-HT.
Measuring the Effect of Ginsenoside Epimers on High K ؉ -or 5-HT-Induced Contraction of the Suspended Swine Coronary Artery Sections For experiments involving high K ϩ , a 25 mM KCl solution was prepared by replacing the NaCl in the physiological salt solution with an equimolar amount of KCl. The solution was saturated with a mixture of 95% O 2 and 5% CO 2 at 37°C and pH 7.4. For stabilization of the artery samples, the intact or endothelium-denuded artery rings were treated with the high KCl solution or 3 mM 5-HT. Once the contraction plateau was achieved, the rings were rinsed five times with warm PSS (37.8°C) and allowed to rest for 30 min in PSS. This procedure was repeated three to four times to confirm the stability of samples. If the amplitudes of contraction in each test showed a deviation of more than 5%, the specimen was excluded from further testing. We then examined the effects of the two ginsenoside epimers in this system. Intact or endothelium-denuded samples were pre-incubated for 1 min with different concentrations of 20(S)-or 20(R)-ginsenoside Rg 3 (1, 3, 10, 30, 100, or 300 mM), and the coronary arteries were again contracted by treatment with 25 mM KCl or 3 mM 5-HT. The inhibitory effects of 20(S)-or 20(R)-ginsenoside Rg 3 were expressed as the percentage of the response with respect to the maximal contraction seen in the presence of 25 mM KCl or 3 mM 5-HT alone. Experiments were repeated four to five times at each concentration, and concentration curves were generated.
Preparation and Microinjection of Xenopus Oocytes Xenopus laevis were obtained from Xenopus I (MI, U.S.A.); their care and handling was performed in accordance with the highest standards of institutional guidelines. Oocytes were surgically isolated from frogs anesthetized with an aerated solution of 3-amino benzoic acid ethyl ester, and separated by treatment with collagenase and agitation for 2 h in a Ca 2ϩ -free medium containing (in mM) 82.5 NaCl, 2 KCl, 1 MgCl 2 , 5 HEPES, 2.5 sodium pyruvate, supplemented with 100 units/ml penicillin and 100 mg/ml streptomycin. Stage V-VI oocytes were collected and stored in ND96 (in mM; 96 NaCl, 2 KCl, 1 MgCl 2 , 1.8 CaCl 2 , and 5 HEPES, pH 7.5) supplemented with 0.5 mM theophylline and 50 mg/ml gentamycin. This oocyte-containing solution was maintained at 18°C with continuous gentle shaking and changed daily. Electrophysiological experiments were performed within 5-6 d of oocyte isolation, using bath application of the noted drugs. For experiments involving Ca 2ϩ channel recordings, one day after harvest, a 10 ml VWR microdispenser (VWR Scientific, CA, U.S.A.) fitted with a tapered glass pipette tip (15-20 mm in diameter) was used to inject 40 nl cRNAs into the animal or vegetal pole of each oocyte.
14)
Data Recording A Plexiglas net chamber was custom designed for the two-electrode voltage-clamp recording. The chamber was constructed by milling two concentric wells into the chamber bottom (diameter/height: upper well: 8/3 mm, lower well: 6/5 mm) and gluing plastic meshes (ca. 0.4 mm grid diameter) onto the bottom of the upper well. A perfusion inlet (ca. 1 mm in diameter) was formed through the wall of the lower well, and a suction tube was placed on the edge of the upper well. When an oocyte was placed on the net separating the upper and lower wells, and the grids of the net served to keep it in place during electrophysiological recording. For experiments, the oocytes were bathed in a recording solution consisting of (in mM) 10 Ba(OH) 2 , 90 NaOH, 2 KOH, 5 HEPES (pH 7.0 adjusted with methanesulfonic acid) and 0.3 niflumic acid, and impaled with two microelectrodes filled with 3 M KCl (0.2-0.7 MW). The electrophysiological experiments were performed at room temperature with an Oocyte Clamp (OC-725C; Warner Instrument, CT, U.S.A.), and stimulation and data acquisition were controlled with a pClamp 8 (Axon Instruments, Union City, CA, U.S.A.). For most of the electrophysiological experiments on Ca 2ϩ channel activity, the oocytes were clamped at a holding potential of Ϫ100 mV and depolarized to 10 mV for 500 ms every 10 s. For examination of current-voltage relationships, voltage steps were applied from Ϫ80 to ϩ60 mV at 10 mV increments.
12)
In Vitro Transcription of cDNAs for Various Ca
2؉
Channel Subunits Recombinant plasmids containing cardiac L-type calcium channel a(a 1C ) subunit cDNA inserts were linearized by digestion with the appropriate restriction enzymes. cRNAs were obtained from the linearized templates with an in vitro transcription kit (mMessage mMachine; Ambion, TX, U.S.A.) using SP6, T3, or T7 RNA polymerases. The resulting RNA was dissolved in RNasefree water at 1 mg/ml, divided into aliquots and stored at Ϫ70°C until use.
12)
Data Analysis To obtain concentration-response curves in the presence of 20(S)-ginsenoside Rg 3 , the peak current amplitudes were obtained and plotted. , K ϩ and Na ϩ channels) and ligand-gated ion channels (e.g. 5-HT 3A and a3b4 nicotinic acetylcholine receptors).
12) Here, we examined whether ginsenoside Rg 3 epimers also exhibited differential effects on high K ϩ -induced coronary artery contractions. Pretreatment of intact and endothelium-denuded swine coronary artery rings with 20(S)-ginsenoside Rg 3 (1 to 300 mM) concentration-dependently inhibited the contraction induced by 25 mM KCl (Figs. 2A, B) . The % inhibition by 20(S)-ginsenoside Rg 3 on coronary artery contraction in intact artery samples was 2.0Ϯ0.9, 2.2Ϯ1.2, 9.2Ϯ1.7, 21.8Ϯ2.2, 72.6Ϯ6.7 and 76.4Ϯ6.0% at ginsenoside doses of 1, 3, 10, 30, 100 and 300 mM, respectively ( Fig. 2A) , while that in endothelium-denuded samples was 3.1Ϯ1.2, 2.8Ϯ2.4, 5.3Ϯ3.6, 12.8Ϯ3.7, 68.5Ϯ7.9 and 72.2Ϯ8.4%, respectively (Fig. 2B) . (Figs. 2A, B) . The IC 50 values of 20(S)-ginsenoside Rg 3 were 46.2Ϯ7.0 and 42.1Ϯ6.7 mM in intact and endothelium-denuded samples, respectively. Interestingly, these IC 50 values were 7-8-fold larger than those obtained from the rat aorta, 10) perhaps due to differences in the utilized organs and species. These results indicate that the inhibitory effect of ginsenoside Rg 3 on high K ϩ -induced coronary artery contraction was stereospecific.
Effects of (S)-and (R)-Ginsenoside Rg 3 on 5-HT-Induced Swine Coronary Artery Contractions
As serotonin (5-HT) is known to induce contraction of mammalian coronary arteries via activation of 5-HT 2A receptors, 15, 16) we next examined whether 20(S)-and 20(R)-ginsenoside Rg 3 exerted similar inhibitory effects on 5-HT-induced swine coronary artery contraction in intact and endothelium-denuded samples. Treatment with both epimers significantly and concentration-dependently inhibited 5-HT-induced contraction in intact coronary artery samples, with 20(S )-ginsenoside Rg 3 showing a slightly but significantly more potent effect than 20(R)-ginsenoside Rg 3 (Fig. 3A) . The % inhibition by 20(S)-ginsenoside Rg 3 on 5-HT-induced coronary artery contraction in intact samples was 0.0Ϯ0.0, 1.7Ϯ1.2, 10.5Ϯ2.4, 24.7Ϯ4.2, 54.7Ϯ5.0 and 53.2Ϯ5.5% at doses of 1, 3, 10, 30, 100 and 300 mM, respectively (IC 50 ϭ31.0Ϯ6.3 mM), while that by 20(R)-ginsenoside was 0.0Ϯ0.0, 0.0Ϯ0.0, 4.2Ϯ1.6, 13.1Ϯ2.3, 32.6Ϯ7.3 and 35.7Ϯ3.7%, respectively (IC 50 ϭ38.6Ϯ2.5 mM). Interestingly, we observed a significant epimer-specific difference in the response of endotheliumdenuded swine coronary artery samples. In these samples, 20(S)-ginsenoside Rg 3 dose-dependently inhibited 5-HT-induced coronary artery contraction, with % inhibition values of 0.0Ϯ0.0, 0.6Ϯ2.1, 6.0Ϯ3.9, 18.7Ϯ5.7, 54.5Ϯ6.4 and 58.5Ϯ7.28% at doses of 1, 3, 10, 30, 100 and 300 mM, respectively (IC 50 ϭ41.0Ϯ4.3 mM) (Fig. 3B) . In contrast, 20(R)-ginsenoside Rg 3 showed less effective inhibition of 5-HT-induced coronary artery contraction in endothelium-denuded samples, with % inhibition values of only 0.0Ϯ0.0, 0.0Ϯ0.0, 0.6Ϯ0.4, 7.5Ϯ3.8, 18.7Ϯ9.6 and 23.8Ϯ5.9% at doses of 1, 3, 10, 30, 100 and 300 mM, respectively (IC 50 ϭ50.2Ϯ4.1 mM) (Fig. 3B) . Since 5-HT is known to induce blood vessel contractions in an endothelium-independent manner, 16, 17) these results further demonstrated that the epimer-specificity of ginsenoside Rg 3 exists through experiments using endothelium-denuded swine coronary arteries. ward Ba 2ϩ peak current (I Ba ) was recorded by the two-electrode voltage clamp technique from oocytes injected with cRNAs encoding the L-type Ca 2ϩ ion channel a and auxiliary subunits. The oocytes were held at Ϫ100 mV for L-type Ca 2ϩ channels 18) and I Ba was elicited by depolarizations to 10 mV, every 10 s for 500 ms. As shown in Fig. 4A (inset) , the depolarizing voltage steps induced large inward I Ba in oocytes expressing L-type Ca 2ϩ channels, but application of various doses of 20(S)-ginsenoside Rg 3 reversibly inhibited this I Ba . Interestingly, treatment with 20(R)-ginsenoside Rg 3 had almost no effect on I Ba (Fig. 4A) . This is consistent with previous findings in experiments using P/Q-type Ca 2ϩ channels.
Effects of 20(S)-Ginsenoside
19)
Concentration-Dependent Effect and Current-Voltage Relationship of the Action of 20(S)-Ginsenoside Rg 3 on L-Type Ca
2؉ Channels Treatment with 20(S)-ginsenoside Rg 3 inhibited I Ba in a dose-dependent manner that became saturated at about 300 mM (Fig. 4A) ; the IC 50 was 39.4Ϯ 2.1 mM for the L-type Ca 2ϩ channels, and the Hill coefficient was 1.3Ϯ0.13. The current-voltage relationships for the Ltype Ca 2ϩ channels were examined in the presence or absence of 100 mM of 20(S )-ginsenoside Rg 3 , with voltage steps from Ϫ80 to ϩ60 mV at Ϫ100 mV holding potentials (Fig.  4B) . Our results revealed that 20(S)-ginsenoside Rg 3 voltagedependently inhibited the peak I Ba of L-type Ca 2ϩ channels, beginning at voltages that were depolarized relative to the resting state.
Although ginseng and its active constituents, ginsenosides, have gained worldwide popularity for their myriad beneficial effects, the underlying mechanisms for these effects have not been fully elucidated. In addition, only a few studies have specifically examined the differential effects of ginsenoside stereoisomers, such as 20(R)-ginsenoside Rg 3 , which may be triggered by 5-HT treatment, is the release of Ca 2ϩ stored in the endoplasmic reticulum in response to activation of phospholipase C-Ga q/11 binding protein-coupled receptors. Activation of 5-HT 2A receptors, which are the predominant vascular receptors mediating contractility to 5-HT and its agonists in the mammalian artery, is coupled to phospholipase C-IP 3 -induced release of intracellular Ca 2ϩ stores from the endoplasmic reticulum. 15, 16) We herein demonstrated that 5-HT-induced swine coronary artery contraction was attenuated by 20(S)-and 20(R)-ginsenoside Rg 3 in intact samples but in endothelium-denuded samples only 20(S)-ginsenoside Rg 3 greatly attenuated 5-HT-induced swine coronary artery contraction (Fig. 3) , suggesting that treatment with 20(S )-ginsenoside Rg 3 attenuates 5-HT-mediated intracellular Ca 2ϩ elevation, resulting in the inhibition of swine coronary artery contraction.
A third alternative may be suggested by the findings that ginsenoside Rg 3 treatment stimulated NO production in the rat aorta, 20, 23) and ginsenoside Re inhibited L-type Ca 2ϩ channel activity via a cGMP-dependent pathway in guineapig cardiomyocytes. 22) Thus, it is possible that the ginsenoside Rg 3 -induced relaxation of coronary arteries might be mediated via cGMP-dependent mechanisms. However, our finding that 20(S)-and 20(R)-ginsenoside Rg 3 might inhibit swine coronary artery contractions mediated by elevation of intracellular Ca 2ϩ levels as well as through L-type Ca 2ϩ channels is consistent with our previous report that ginsenosides may regulate intracellular Ca 2ϩ levels in different manners between excitable cells (e.g. neurons) versus non-neuronal cells. 19) For example, ginsenosides were shown to increase intracellular Ca 2ϩ levels in non-neuronal cells such as Xenopus laevis oocytes, whereas ginsenoside treatment attenuated both L-type Ca 2ϩ channel-mediated and stored releasebased intracellular Ca 2ϩ increases in rat hippocampal neurons. 19 ) Future studies will be required to assess these possibilities.
Interestingly, the inhibitory potency of 20(R)-ginsenoside Rg 3 on 5-HT-induced swine coronary artery contraction in intact samples was 30-40% less than that of 20(S )-ginsenoside Rg 3 . This difference in potency might be derived from their chemical structures with a change in the position of the hydroxyl group on carbon-20 ( Fig. 1) . We previously showed that 20(S)-but not 20(R)-ginsenoside Rg 3 inhibited voltagedependent Ca 2ϩ , K ϩ and Na ϩ channel activations, and also showed that 20(S)-ginsenoside Rg 3 inhibited 5-HT 3A -and nicotinic acetylcholine receptor-mediated ion currents more effectively than 20(R)-ginsenoside Rg 3 in Xenopus oocytes, 12) suggesting that the position of the hydroxyl group on carbon-20 of ginsenoside Rg 3 might play an important role to exhibit the differential effects in ion channel regulations and in coronary artery relaxation and furthermore indicating that its hydroxyl group might be one of the important functional groups considered in new drug designs or developments using ginsenosides in future.
In summary, we herein show for the first time that 20(S)-but not 20(R)-ginsenoside Rg 3 potently and dose-dependently inhibited high K ϩ -and 5-HT-induced swine coronary artery contractions, suggesting that 20(S)-ginsenoside Rg 3 might be a useful agent for vasorelaxation, which is achieved via inhibition of the elevation of intracellular Ca 2ϩ level mediated by L-type Ca 2ϩ channel or 5-HT receptor activation.
